Qutenza kit is a prescription medicine containing Capsaicin, marketed by Averitas Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store carton between 20°C to 25°C (68°F to 77°F). Excursions between 15°C and…
Key facts
- Active ingredient (INN)
- Capsaicin
- Brand
- Qutenza
- Dosage form
- Kit
- Packs
- 1 kit
- Marketing authorisation holder
- Averitas Pharma
- Manufacturer
- Averitas Pharma
- Origin register
- US FDA, United States
- Storage
- Store carton between 20°C to 25°C (68°F to 77°F). Excursions between 15°C and 30°C (59°F and 86°F) are allowed.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- M02AB01 Capsaicin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 October 2018
- Identifiers
- RxCUI 1039679, 1039681DailyMed set ID 3ffbbcb0-ad93-4f15-bb38-5da76a71c735NDC 72512-929, 72512-928, 72512-930Application NDA022395
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 carton * 1 pouch in 1 carton / 1 patch in 1 pouch / 179 mg in 1 patch * 50 g in 1 tube | 72512-928-01 | Averitas Pharma | 30 October 2018 |
| 1 kit in 1 carton * 2 pouch in 1 carton / 1 patch in 1 pouch / 179 mg in 1 patch * 50 g in 1 tube | 72512-929-01 | Averitas Pharma | 30 October 2018 |
| 1 kit in 1 carton * 4 pouch in 1 carton / 1 patch in 1 pouch / 179 mg in 1 patch * 3 tube in 1 carton / 50 g in 1 tube | 72512-930-01 | Averitas Pharma | 25 March 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Capsaicin is a prescription medicine indicated in adults for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and for neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet. It is available as kits. MedsAcross supplies Capsaicin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CapsaicinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Qutenza prescribing information (Averitas Pharma) · U.S. National Library of Medicine, DailyMed
- Qutenza: European public assessment report (EPAR) · European Medicines Agency
Need Qutenza kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.